Where does Joimax GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Joimax GMBH ranks #16,912 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Joimax GMBH hold?

Joimax GMBH holds 17 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Joimax GMBH's Innovation Score?

Joimax GMBH has an Innovation Score of 43.4 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Joimax GMBH focus on?

Joimax GMBH's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 14 patents, ranking #1,252 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Joimax GMBH's patent grant rate increasing or decreasing?

Joimax GMBH's recent grant velocity is +29% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Joimax GMBH's patents?

Joimax GMBH's patents average 21.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Joimax GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Joimax GMBH

USPTO PatentsView assignee record - 17 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Joimax ranks #16,912 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 4 technology areas.

#16,912
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.4/100): 21.7
avg claims per patent: +29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16912 · Foreign Corporation #16,912 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #16,912/49,997
PHOTO-FINISH Jace Medical
CPC-NARROW A61B · 4 areas
INNOV-PAR 43.4/100
CLAIMS-DENSE 21.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jace Medical, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Joimax’s 43.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (23%) Velocity 13.3 pts (31%) Breadth 7.1 pts (16%) Claim depth 13.0 pts (30%)

Qualcomm Incorporated · highest

85
Joimax · this assignee

43
3D Lighting… · lowest

7

What this shows Joimax's Innovation Score is 43.4/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Joimax?

Each dot is one of Joimax’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Joimax’s own 21.7 claims/patent is ABOVE the 9.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Joimax vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Joimax's grants concentrate

Joimax GMBH is a focused PatentsView assignee: 4 CPC subclasses with 82.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2015. By volume, Joimax sits between J&S Co., Ltd. and Justrite Manufacturing Company, L.L.C..

Joimax's three-year grant acceleration

Joimax GMBH shows 8 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

J&S

17
Jain Irrigation S…

17
Jiangsu Leuven In…

17
JNC Fibers

17
Joint Stock “Akme…

17
Jace Medical

17
Jetsmarter

17
Justrite Manufact…

17
Joimax ◀

17

What this shows Joimax holds 17 patents at rank #16,910, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Joimax

By rank, the assignees closest to #16,910 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Joimax's primary technology class.

Joimax's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Joimax GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.9%
2016	2	11.8%
2018	1	5.9%
2019	3	17.6%
2020	1	5.9%
2022	2	11.8%
2023	4	23.5%
2024	2	11.8%
2025partial year	1	5.9%

Which technologies does Joimax GMBH patent most?

A61B - DIAGNOSIS; SURGERY; Identification 14

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 1

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Joimax GMBH's patent record in context - here's where to go next.

Joimax GMBH's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 82.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #16,912 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Joimax GMBH against J&S Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.